Fact CheckerSign in

NCT07462221Recruiting

Effect of Telenursing on Oral Health

The Effect of Telenursing Interventions on Oral Health in Individuals With COPD

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

This research will be conducted using a pre-test and post-test control group experimental design to evaluate the effect of telenursing intervention on oral health in individuals with COPD.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
5 Mar 2026
Start date
4 Mar 2026
Primary completion date
4 Mar 2026
Lead sponsor
Çanakkale Onsekiz Mart University
Diseases
COPD
NCT number
NCT07462221

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 4 Mar 2026 to the primary completion date, 4 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those receiving outpatient treatment,

Age

  • Those under 40 years of age,

Other

  • Those diagnosed with COPD less than 6 months ago,
  • Those hospitalized in the intensive care unit,
  • Those without internet access and a mobile device with Android/iOS operating system,
  • Those who do not have the ability to use a phone,
  • Those with communication barriers,
  • Those who wish to withdraw from the research/withdraw from participation during the research process,

Who the study is looking for

  • Participants must have been diagnosed with COPD for at least 6 months,
  • receive inpatient treatment in internal medicine and surgical clinics,
  • signed the informed consent form to participate in the study,
  • have internet access and a mobile device with Android/iOS operating system,
  • be able to use a phone,
  • ≥ 40 years old,
  • have no communication barriers,
  • mild (Stage 1), moderate (Stage 2), severe (Stage 3), or very severe (Stage 4) stages according to the GOLD (2023) report.

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University
Coordinator of this site? Confirm its status
ÇanakkaleTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.